Our reporters bring you news and highlights from BIO’s in-person and virtual events.
The Council of State Bioscience Associations (CSBA), a coalition of state-based bioscience trade associations convened by BIO, joined forces in Washington DC on Tuesday and …
CSBA hits Capitol Hill for face time with lawmakers Read More »
When it comes to long COVID, health care providers and the biotech industry must be aware of what is already known, but we still need …
BIO’s long COVID webinar furthers search for biotech solutions Read More »
While research into long COVID-19 is offering clues to causes and potential targets for treatment, defeating this debilitating condition, which impacts millions, requires a team …
BIO’s online conference invites biotech to join in fighting long COVID Read More »
Eleven years after the first CRISPR patent was filed, we’re anticipating what could be the first approval of a gene therapy based on CRISPR: exa-cel, …
‘How do you price a cure?’ and other questions about the CRISPR era Read More »
The number of new pain drugs in the development pipeline has slowed to a trickle and investment in addiction drugs is low, challenges addressed during …
‘All hands on deck’ needed to address U.S. pain and addiction innovation Read More »
The Inflation Reduction Act’s drug price controls have been a hot topic during the BIO CEO and Investor Conference—and one that has hampered an otherwise …
We’re already seeing the impact of drug price controls, say biotech CEOs Read More »
“I think we’re in a very exciting time in healthcare and biotech,” said Steven Ladd, Director of Business Development and Acquisitions at AbbVie. “It’s about …
China-U.S. biotech ventures are where collaboration meets competition Read More »
The narrative is that it’s a bad market for biotech, but CEOs and investors told a packed house at the 2023 BIO CEO and Investor …
Are SPACs dead? – and other questions about the biotech market outlook Read More »
On Day 1 of the BIO CEO and Investor Conference, a panel—Prioritizing CRO Spending Through a High-Inflation, Sparse-Funding Period—brought together experts to look at how …
“It’s exciting times,” said Kathy Fernando, Senior Vice President and Global Head of the Partner of Choice Organization at Pfizer Inc. Speaking about the newly …
Pfizer Ignite’s new model is turning heads and sharing the wealth Read More »
The teams behind Good Day BIO and Bio.News is live at the BIO CEO and Investor Conference in New York. The Marriott Marquis in Times …
How to follow the BIO CEO and Investor Conference 2023 Read More »
